Biden administration to extend transportation mask mandate for 15 more days

Biden administration to extend transportation mask mandate for 15 more days


Travelers wait in line at a Transportation Security Administration (TSA) screening checkpoint at Orlando International Airport on the Friday before Memorial Day. As more and more people have received the COVID-19 vaccine, American Automobile Association (AAA) is predicting more than 37 million Americans will travel more than 50 miles this Memorial Day weekend, many for the first time since the pandemic began.

Paul Hennessy | LightRocket | Getty Images

The Biden administration will extend the mask mandate for airplanes and transit for 15 days, according to people familiar with the matter.

The mandate was set to expire after April 18, following a one-month extension in March. Airlines have required masks on planes since early in the pandemic in 2020, but the Biden administration made them mandatory in early 2021.

Airlines have repeatedly asked the administration to drop that requirement as well as other Covid restrictions such as predeparture testing for all international arrivals, including citizens.

This is breaking news. Check back for updates.



Source

2026 is the year of obesity pills. Here’s how they could reshape the GLP-1 market
Health

2026 is the year of obesity pills. Here’s how they could reshape the GLP-1 market

The booming GLP-1 space was built on weekly injections. In 2026, new obesity pills will push the market into its next chapter. Patients are already getting their hands on the first GLP-1 pill for obesity from Danish drugmaker Novo Nordisk — a once-daily drug that shares the same brand name as its popular injection Wegovy. […]

Read More
Healthy Returns: What to expect from pharma at the JPM conference
Health

Healthy Returns: What to expect from pharma at the JPM conference

Heidi Overton, Novo Nordisk CEO Maziar Mike Doustdar, Eli Lilly CEO David A. Ricks, and U.S. Secretary of Commerce Howard Lutnick listen while U.S. President Donald Trump announces a deal with Eli Lilly and Novo Nordisk on to reduce the prices of GLP-1 weight‑loss drugs during an event in the Oval Office at the White […]

Read More
A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year
Health

A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year

Europe’s best-performing blue-chip stock in 2025 is widely expected to be bought by a larger peer, in a deal analysts say could be worth as much as $23 billion. Abivax, the French clinical-stage biotech company developing a treatment for ulcerative colitis and Crohn’s disease, saw shares rocket 1,681% last year, far outpacing the Stoxx 600 […]

Read More